ADIPOQ and metabolic dysfunction-associated steatotic liver disease: The results of a recent study [23] show that the ratio of FGF21/adiponectin is higher in subjects with NAFLD than in those without NAFLD, and that there was a positive relationship between change in the ratio and liver fat percentage in individuals enrolled in a clinical weight loss program.